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TO THE EDITOR
Polymorphism–disease association stu-
dies have been of increasing impor-
tance in the discovery of genetic
backgrounds of multifactorial disorders;
their value can be further increased by
independent multiple investigations in
geographically and ethnically distant
populations. This commentary letter
refers to an article by Wallace et al.
(2006), recently published in this jour-
nal. Wallace et al. found a higher
incidence of the A allele of 308 G/A
single nucleotide polymorphism (SNP)
located in the promoter region of the
tumor necrosis factor-a (TNFa) gene
among venous leg ulcer patients than
in healthy controls.
TNFa is a potent pleiotropic pro-
inflammatory cytokine with effects on
lipid metabolism, coagulation, insulin
resistance, and endothelial functions. It
mediates several biological processes
including wound healing (Crist et al.,
2004; Babbar et al., 2006). It has also
been demonstrated that TNFa is down-
regulated in wound fluid from non-
healing venous leg ulcers when com-
pared with healing venous leg ulcers
(Wallace and Stacey, 1998).
Venous leg ulcer is a multifactorial
disorder; both genetic and environmen-
tal factors play essential roles in its
pathogenesis; however, the pathome-
chanism of the disease is still not fully
understood. Therefore, detecting SNPs,
which might play a role in the devel-
opment of venous leg ulcer, could
result in identifying genetic factors
leading to leg ulcer susceptibility (Nagy
et al., 2005). The 308 G/A poly-
morphism of the TNFa gene reported
by Wallace et al. (2006) is the first TNFa
SNP associated with wound healing
and susceptibility for venous leg ulcer.
The 308 TNFa SNP has been inten-
sively studied previously. Among many
other human diseases (Cancello et al.,
2004), its A allele has been linked to
obesity and insulin resistance as well
(Hoffstedt et al., 2000; Brand et al.,
2001); however, others could not prove
this connection (Walston et al., 1999).
This study compared the frequency of
the 308 G/A TNFa SNP in venous leg
ulcer patients (n¼ 151) and in healthy
controls (n¼ 92) in the Hungarian popu-
lation. Because the 308 polymorphism
of TNFa has been linked to increased
obesity risk, the group of leg ulcer
patients was divided into two subgroups:
leg ulcer patients with body mass index
(BMI)o25 kg/m2 (n¼ 110) and with
BMI425 kg/m2 (n¼ 41). Leg ulcer pa-
tients with diabetes, both type 1 and type
2, were excluded from the study. Venous
leg ulcer patients were also screened for
trauma, erysipelas, cardiac diseases,
atherosclerosis, and autoimmune disor-
ders. A leg-ulcer-free control group was
divided into two groups: with
BMIo25 kg/m2 (n¼92) and with
BMI425 kg/m2 (n¼ 39). Informed con-
sent, approved by the Internal Review
Board, was obtained from all donors; the
study was conducted according to the
Declaration of Helsinki Principles.
Blood samples were taken from all
participants (n¼ 282), and DNA was
isolated by a standard proteinase K
digestion method (Eppendorf AG, Ham-
burg, Germany). The TNFa 308 G/A
SNP was genotyped by the PCR-restric-
tion-fragment length polymorphism
(RFLP) method: 100 ng of genomic
DNA was used for PCR amplification
and a 147-nt long region of the TNFa
promoter harboring the SNP was am-
plified by PCR using the following
primers: forward 50-gaggcaataggtttt
gagggccat-30, reverse 50-gggacacacaag
catcaag-30. NcoI (Fermantas, Vilnius,
Lithuania) restriction enzyme digestion
was performed to distinguish the 308
G/A alleles using 10 ml of the PCR
products, run on 5% Nusieve agarose
gels (Cambrex, Berkshire, UK) and
photographed. The amplified wild-type
(GG) PCR product was cut at one
position by NcoI, resulting in 121- and
26-nt long bands; the amplified homo-
zygote mutant (AA) PCR product was
not cut. Therefore the original 147-nt
PCR product was detected, and the
heterozygote mutant genotype was
characterized by a pattern of 147,
121, and 26 nt products.
Statistical analysis was carried out
on the groups of leg ulcer patients and
controls according to the rules of case–-
control allelic association study design.
The statistical significance of associa-
tion between the 308 TNFa SNP and
venous leg ulcer was assessed by the
Fisher exact probability test, and odds
ratios (ORs) with 95% confidence
intervals (CIs) were also calculated
(VassarStats, http://faculty.vassar.edu/
lowry/VassarStats.html). To be compar-
able with the referred paper (Wallace
et al., 2006), logistic regression analysis
was also carried out.
When we compared the data of
the non-obese venous leg ulcer patients
(BMIo25 kg/m2) with non-obese heal-
thy controls (BMIo25 kg/m2), we could
not detect a difference in the mutant (A)
allele frequency of the 308 TNFa
SNP. However, the mutant allele fre-
quency of the 308 TNFa SNP showed
a significant difference (Fisher exact
probability test P¼0.0273, OR (95%
CI)¼1.88 (0.9533–3.6877)): simple
logistic regression analysis P¼0.0514)
between obese venous leg ulcer patients
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(BMI425kg/m2) and non-obese healthy
controls (BMIo25kg/m2) (Table 1). We
also compared the genotype data of the
308 TNFa SNP of the unified group
of leg ulcer patients without consi-
dering their BMI with healthy controls,
but there was no difference. Our data
are in agreement with the findings of
Hoffstedt et al. (2000) and Brand et al.
(2001); we found a higher frequency of A
allele of TNFa 308 SNP in the
obese control group compared with the
non-obese control group (Fisher exact
probability test P¼ 0.0457, OR (95%
CI)¼1.72 (0.8567–3.4549)).
According to our data, the level of
association between 308 TNFa SNP
and venous leg ulcer susceptibility might
depend on the BMI of the Hungarian
individuals enrolled in the study. As
obesity was not considered in the
Wallace paper, there is a possibility that
the association between the A allele of
the 308 TNFa SNP and leg ulcer
susceptibility they found was because
of the suspected high rate of obese
individuals in the Australian leg ulcer
patients’ group. Thus, our results are in
agreement with the conclusion of Wal-
lace et al. (2006) that the A allele of the
308 TNFa SNP might be a potential
factor for venous leg ulcer susceptibility;
however, our data suggest that this
association is secondary and the primary
association probably exists with obesity.
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Table 1. PCR-RFLP data of the 308 G/A polymorphism of the TNFa gene
GG GA AA
TNFa gene 308 G/A SNP M2 F2 M F M F G A
Fisher’s1
test
Odds
ratio 95% CI of OR
Leg ulcer patients with BMI425 kg/m2 (n=41) (group 1) 25 (60.98) 14 (34.15) 2 (4.88) 64 18 P=0.0273 1.88 0.9533–3.6877
9 16 6 8 1 1
Leg ulcer patients with BMIo25 kg/m2 (n=110) (group 2) 76 (69.09) 31 (28.18) 3 (2.73) 183 37 P=0.0643 1.35 0.7732–2.3498
31 45 12 19 1 2
All leg ulcer patients (n=151) (group 1+2) 101 (66.89) 45 (29.80) 5 (3.31) 247 55 P=0.0334 1.49 0.8834–2.4948
40 61 18 27 2 3
Leg-ulcer-free controls with BMI425 kg/m2 (n=39)
(group 3)
24 (61.54) 14 (35.90) 1 (2.56) 62 16 P=0.0457 1.72 0.8567–3.4549
0 24 0 14 0 1
Leg-ulcer-free controls with BMIo25 kg/m2 (n=92)
(group 4)
68 (73.91) 24 (26.09) 0 160 24
29 39 11 13 0 0
All leg-ulcer-free controls (n=131) (group 3+4) 92 (70.23) 38 (29.01) 1 (0.76) 222 40 P=0.0888 1.20 0.6963–2.0724
29 63 11 27 0 1
BMI, body mass index; RFLP, restriction-fragment length polymorphism; TNFa, tumor necrosis factor-a.
Data in parentheses show numbers of individuals with percentages.
1Fisher’s exact probability test was calculated using allele frequency data of the A and G alleles.
2M, number of males; F, number of females.
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